Response to: 'Not all drugs (and routes) are same' by Zanwar and Gandhi
- PMID: 29858174
- DOI: 10.1136/annrheumdis-2018-213742
Response to: 'Not all drugs (and routes) are same' by Zanwar and Gandhi
Keywords: cyclophosphamide; treatment.
Conflict of interest statement
Competing interests: None declared.
Comment on
-
Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2).Ann Rheum Dis. 2018 Aug;77(8):1143-1149. doi: 10.1136/annrheumdis-2017-212878. Epub 2018 Apr 25. Ann Rheum Dis. 2018. PMID: 29695500 Clinical Trial.
-
'Not all drugs (and route) are same'.Ann Rheum Dis. 2019 Aug;78(8):e74. doi: 10.1136/annrheumdis-2018-213730. Epub 2018 Jun 1. Ann Rheum Dis. 2019. PMID: 29858175 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources